Cylindromatosis 1 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cylindromatosis 1 monoclonal antibodies for research focused on understanding cylindromatosis 1 protein function. Cylindromatosis 1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cylindromatosis 1, also known as CYLD, is a critical tumor suppressor protein that plays a significant role in regulating cell signaling pathways, particularly those involved in inflammation and cell proliferation. CYLD function is essential in maintaining cellular homeostasis, and mutations in the CYLD gene have been linked to the development of various tumors, including cylindromas and other skin neoplasms. Understanding CYLD mechanisms can provide insights into cancer biology and potential therapeutic targets. Cylindromatosis 1 monoclonal antibodies enable precise detection and analysis of CYLD expression patterns across different tissue types. Researchers can investigate CYLD's role in various cellular processes and signaling cascades using specific detection methods. Santa Cruz Biotechnology monoclonal antibodies for Cylindromatosis 1 support researchers worldwide in advancing our understanding of cancer biology and therapeutic development.